The Next Billion Dollar Medical Breakthrough - June 16, 2017

No debt. No venture capital. Profitable since year three. FDA clearances are in-hand. What's next, IPO? Ra Medical Co-founder/CEO Dean Irwin talks about how a technology, once only used for LASIK surgery, has now been adapted to tackle the number one killer in America, Cardiovascular Disease. Their ultimate goal with this technology? To prevent heart attacks by unclogging coronary arteries. Despite what your mother always told you growing up about sun exposure, UV radiation can actually be life-saving. Dean Irwin, co-founder of DABRA and CEO of RA Medica will tell us how his company harnesses the power of the sun to create a huge medical breakthrough. The excimer laser combines gases that react to create a laser light in the ultraviolet range. RA Medical has turned this laser into a medical miracle that can ablate right through the rock hard calcium and other buildup in the arteries, turning it back into its constituent, pre-existing components. The most recent news? DABRA has just received FDA approval for clinical trial and funding from Medicare. DABRA stands for Destruction of Arteriosclerotic Blockages by Laser Radiation Ablation. Dean combines his skills such as chemistry, optics and mechanics to uncover next-level medical inventions. He took his knowledge of electronics and how that kind of power system works and began to apply it to the excimer laser. After much trouble and set-back at General Atomics, Dean eventually started RA Medical when he was able to discover the ideal wavelength of the excimer laser to treat specific disorders. Dean took that model and evolved it into the PHAROS excimer laser that sends embarrassing skin conditions such psoriasis and vitiligo into remission. Now, with the DABRA laser, RA Medical is treating patients who suffer cardiovascular diseases using liquid instead of glass. They find that the excimer laser catheter, or DABRA, also keeps the physicians out of trouble. It doesn't have a lot of adverse events. In fact, in their pilot study, they did not have a single adverse event. A very rare, safe, and affordable cure is what this is! Doctors are keen to start using the DABRA because of the lack of a solution for 100% blockages in which a guidewire cannot cross through. RA Medical hopes to move the DABRA system beyond Peripheral Artery Disease. They see greater applications for arteries feeding the heart, as well as applications unclogging stents (in-stent restenosis). More FDA studies to come.